Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines

Cancer Chemotherapy and Pharmacology

Volumn 49, Issue 1, 2002, Pages 78-86

  Lee, Terence ^a   Lau, Tracy ^a   Ng, Irene ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Chemosensitivity; DOX; p53 p21

Indexed keywords

DNA FRAGMENT; DOXORUBICIN; MUTANT PROTEIN; PROTEIN MDM2; PROTEIN P21; PROTEIN P27; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DEATH; CELL LINE; CELL STRAIN HEPG2; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; FLOW CYTOMETRY; GENE MUTATION; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; WESTERN BLOTTING; CANCER CELL; CELL KILLING; DNA DAMAGE; DRUG SENSITIVITY; LIVER CELL CARCINOMA; PROTEIN FUNCTION; UPREGULATION;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL CYCLE PROTEINS; DNA DAMAGE; DNA FRAGMENTATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036137529     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-001-0376-4     Document Type: Article

References (46)

1. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: Etoposide inhibits the p53-Mdm2 autoregulatory feedback loop
2. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer
3. Prospects for epidemiological studies on hepatocellular cancer as a model for assessing viral and chemical interactions
4. Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines
5. Mapping of the p53 and mdm-2 interaction domains
6. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene
7. mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein
8. Thymocyte apoptosis induced by p53-dependent and independent pathways
9. p53 activity and chemotherapy
10. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents
11. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
12. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
13. Checkpoints: Controls that ensure the order of cell cycle events
14. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents
15. DNA damage by filtered, tar- and aerosol-free cigarette smoke in rodent cells: A novel evaluation
16. p53 mutations in human cancers
17. Anthracyclines in the treatment of cancer. An overview
18. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
19. Control of G1 arrest after DNA damage
20. Participation of p53 protein in the cellular response to DNA damage
21. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
22. Molecular interrelationships in multidrug resistance
23. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents
24. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
25. p53 is required for radiation-induced apoptosis in mouse thymocytes
26. Retroviral insertional mutagenesis as a strategy for the identification of genes associated with cis-diamminedichloroplatinum (II) resistance
27. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells
28. Human p53 gene localized to short arm of chromosome 17
29. Wild-type p53 induces apoptosis in Hep3B through up-regulation of bax expression
30. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
31. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
32. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
33. The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents
34. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium
35. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
36. Cloning and expression of daunorubicin biosynthesis genes from Streptomyces peucetius and S. peucetius subsp. caesius
37. The mdm-2 gene is induced in response to UV light in a p53 dependent manner
38. Estimates of the worldwide mortality from eighteen major caners in 1985. Implications for prevention and projections of future burden
39. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage
40. Involvement of the p53 tumor suppressor in repair of UV-type DNA damage
41. Hepatitis C virus, a causative infectious agent of non-A, non-B hepatitis: Prevalence and structure - Summary of a conference on hepatitis C virus as a cause of hepatocellular carcinoma
42. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
43. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis
44. Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53
45. The p53-mdm-2 autoregulatory feedback loop
46. Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene